Article
Ribonucleotide reductase M1 (RRM1) 2464G>A polymorphism shows an association with gemcitabine chemosensitivity in cancer cell lines.
Pharmacogenetics and genomics - 1 Jun 2006
Kwon Woo Sun, Rha Sun Young, Choi Yeon Ho, Lee Jung Ok, Park Kyu Hyun, Jung Jae Joon, Kim Tae Soo, Jeung Hei-Cheul, Chung Hyun Cheol
Abstract excerpt
OBJECTIVES: Significant variability in the efficacy and toxicity of an anticancer drug is observed in cancer patients. Currently, there are no standard tools for prediction of a patient's tumor response or his risk of adverse events to chemotherapy. METHODS: We investigate an association between polymorphisms of gemcitabine metabolism-related genes and its chemosensitivity in vitro using 62 human cancer cell...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
